Aspen Pharmacare Holdings Limited
APNHF
$7.25
$0.8813.82%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.48B | 2.43B | 2.39B | 2.33B | 2.32B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.48B | 2.43B | 2.39B | 2.33B | 2.32B |
| Cost of Revenue | 1.36B | 1.36B | 1.35B | 1.30B | 1.27B |
| Gross Profit | 1.12B | 1.08B | 1.04B | 1.03B | 1.04B |
| SG&A Expenses | 571.99M | 555.55M | 540.14M | 530.67M | 530.17M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 45.44M | 34.01M | 22.77M | 35.87M | 48.93M |
| Total Operating Expenses | 1.98B | 1.94B | 1.92B | 1.87B | 1.85B |
| Operating Income | 505.26M | 489.96M | 475.40M | 465.09M | 464.24M |
| Income Before Tax | 327.50M | 316.24M | 305.59M | 317.32M | 334.86M |
| Income Tax Expenses | 82.69M | 76.30M | 70.05M | 69.61M | 70.47M |
| Earnings from Continuing Operations | 244.81 | 239.94 | 235.54 | 247.71 | 264.39 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 244.81M | 239.94M | 235.54M | 247.71M | 264.39M |
| EBIT | 505.26M | 489.96M | 475.40M | 465.09M | 464.24M |
| EBITDA | 588.05M | 568.95M | 550.79M | 538.68M | 536.79M |
| EPS Basic | 0.55 | 0.54 | 0.53 | 0.56 | 0.60 |
| Normalized Basic EPS | 0.60 | 0.59 | 0.57 | 0.56 | 0.56 |
| EPS Diluted | 0.55 | 0.54 | 0.53 | 0.56 | 0.60 |
| Normalized Diluted EPS | 0.60 | 0.59 | 0.57 | 0.56 | 0.56 |
| Average Basic Shares Outstanding | 1.78B | 1.78B | 1.78B | 1.78B | 1.78B |
| Average Diluted Shares Outstanding | 1.78B | 1.78B | 1.78B | 1.78B | 1.78B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 36.48% | 35.56% | 34.67% | 32.97% | 30.89% |